source
- Roche scraps two Ionis-partnered Huntington’s drugsThe Swiss pharmaceutical giant told patient groups tominersen didn't delay disease progression in one trial, while a study of a second drug was scrapped because of a safety signal in animal testing.BioPharma Dive · 21d ago↗ source
- Whistleblower takes on health insurance and FDA commissioner candidatesThis week on "The Readout LOUD" podcast: Why does getting family health insurance through a job cost as much as buying a new car? And who might be the new…STAT · 21d ago↗ source
- GSK ends brain drug alliance with AlectorClinical setbacks derailed what was once a potentially $2.2 billion deal that marked GSK's return to neuroscience.BioPharma Dive · 21d ago